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To cite this article: (2019) ISEV2019 Abstract Book, Journal of Extracellular Vesicles, 8:sup1, 1593587, DOI: 10.1080 /20013078.2019 To link to this article: https://doi.org/10. 1080 /20013078.2019 .1593587 © 2019 Introduction: Recent advancements in flow cytometry (FCM) have led to the development of high-resolution FCMs dedicated to the analysis of small particles (hFCM). hFCM studies have predominantly focused on the analysis of EVs expressing phosphatidylserine (PS). PS is enriched in microvesicles (MVs), wherein it is involved in lipid rearrangements responsible for MV budding. While PS also is expressed on exosomes, it is unknown whether it can be used as a universal marker for smaller EVs. In this study, we attempted to characterize proteins enriched in smaller EVs (CD9, CD63, CD81 and ADAM 10) and the relative co-expression of PS with each of these markers. Methods: FCM analysis was performed on an Apogee A60 Micro-PLUS. In brief, platelet-poor plasma (PPP) from healthy individuals was stained with lactadherin-FITC (PS+) and one of several EV surface markers enriched in smaller EVs. To evaluate the precise differences in PS and specific EV marker expression, the analysis was performed twice, (1) triggering on lactadherin and (2) each EV marker (CD9-PE, CD81-PE, CD63-PE, ADAM10-PE), separately. All antibodies were matched with appropriate isotope controls and centrifuged at 17,000g for 10 min prior to antibody labelling. EVs were defined as lactadherin or EV surface marker positive events ≤1000 nm. 
